Skip to content

Clinical trials

Carcinoma, Bronchogenic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20111
20121
20131
20161
20174
20181
20191
20201
20213
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation4
Eli Lilly and Company3
Hoffmann-La Roche2
Revolution Medicines, Inc.2
VA Office of Research and Development2
Weill Medical College of Cornell University2
H. Lee Moffitt Cancer Center and Research Institute1
National Institutes of Health Clinical Center (CC)1
NovaRx Corporation1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic23
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung20
Neoplasms20
Neoplasms by Site18
Thoracic Neoplasms18
Respiratory Tract Diseases17
Respiratory Tract Neoplasms17
Lung Diseases16
Bronchial Neoplasms15

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.